Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
quadrivalent Lactobacillus live vaginal capsule
- Development stage
- Unknown
- Lead developer
- Sichuan Anaerobio Technology
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Vaginal
01
Overview
Quadrivalent Lactobacillus live vaginal capsule (KAL-001) is a live biotherapeutic product (LBP) developed by Sichuan Anaerobio Technology for the treatment and prevention of recurrent bacterial vaginosis (BV). The formulation contains four distinct strains of live *Lactobacillus* species, which are the dominant beneficial bacteria in a healthy vaginal ecosystem. Following antibiotic induction therapy, the capsule is administered intravaginally to re-establish a protective microbial environment, produce lactic acid to maintain a low pH, and inhibit the colonization of pathogenic anaerobic bacteria. It is currently undergoing Phase III clinical evaluation in China.
- Other names
- 阴道四价乳杆菌活菌胶囊Vaginal Quadrivalent Lactobacillus Live Capsule
02
Targets
VME (Vaginal microbiota ecosystem)
Beyond the preview
Go deeper on quadrivalent Lactobacillus live vaginal capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on quadrivalent Lactobacillus live vaginal capsule.